Home/Filings/4/0001127602-23-004512
4//SEC Filing

Ridha Essra 4

Accession 0001127602-23-004512

CIK 0001681087other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:14 PM ET

Size

5.2 KB

Accession

0001127602-23-004512

Insider Transaction Report

Form 4
Period: 2023-02-08
Ridha Essra
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Unit

    2023-02-08+131,333131,333 total
    Exercise: $0.00Exp: 2027-02-01Common Stock (131,333 underlying)
Footnotes (1)
  • [F1]The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.

Issuer

AVROBIO, Inc.

CIK 0001681087

Entity typeother

Related Parties

1
  • filerCIK 0001888732

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:14 PM ET
Size
5.2 KB